The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: Results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial

Quality of Life Research

Volumn 23, Issue 6, 2014, Pages 1841-1858

  Hoffman, Karen E ^a   Pugh, Stephanie L ^b   James, Jennifer L ^b   Scarantino, Charles ^c   Movsas, Benjamin ^d   Valicenti, Richard K ^e   Fortin, Andre ^f   Pollock, Jondavid ^g   Kim, Harold ^h   Brachman, David G ⁱ   Berk, Lawrence B ^j   Bruner, Deborah Watkins ^k   Kachnic, Lisa A ^l  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RTOG Statistical Center   (United States)

^c Rex Cancer Center UNC Healthcare   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LAVAL UNIVERSITY   (Canada)

^g WHEELING HOSPITAL   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

ⁱ Arizona Oncology Services   (United States)

^j H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^l BOSTON MEDICAL CENTER   (United States)

more..

Author keywords

GM CSF; Head and neck cancer; Quality of life; Radiation mucositis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RADIOPROTECTIVE AGENT;

ARTICLE; CANADA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; DOUBLE BLIND PROCEDURE; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; UNITED STATES;

CANADA; COST OF ILLNESS; DOUBLE-BLIND METHOD; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRES; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84905279485     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-014-0628-5     Document Type: Article

References (21)

1. Trotti, A., Bellm, L. A., Epstein, J. B., Frame, D., Fuchs, H. J., Gwede, C. K., et al. (2003). Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiotherapy and Oncology, 66(3), 253-262.
2. Rosenthal, D. I. (2007). Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. The Journal of Supportive Oncology, 5(9 Suppl 4), 23-31.
3. Suntharalingam, M., Haas, M. L., Van Echo, D. A., Haddad, R., Jacobs, M. C., Levy, S., et al. (2001). Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck. Cancer, 91(3), 548-554.
4. Elting, L. S., Cooksley, C. D., Chambers, M. S., & Garden, A. S. (2007). Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. International Journal of Radiation Oncology Biology Physics, 68(4), 1110-1120.
5. Bjordal, K., Ahlner-Elmqvist, M., Hammerlid, E., Boysen, M., Evensen, J. F., Biorklund, A., et al. (2001). A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope, 111(8), 1440-1452.
6. Epstein, J. B., Robertson, M., Emerton, S., Phillips, N., & Stevenson-Moore, P. (2001). Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head and Neck, 23(5), 389-398.
7. List, M. A., Siston, A., Haraf, D., Schumm, P., Kies, M., Stenson, K., et al. (1999). Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination. Journal of Clinical Oncology, 17(3), 1020-1028.
8. Nicolatou, O., Sotiropoulou-Lontou, A., Skarlatos, J., Kyprianou, K., Kolitsi, G., & Dardoufas, K. (1998). A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report. International Journal of Radiation Oncology Biology Physics, 42(3), 551-556.
9. Kannan, V., Bapsy, P. P., Anantha, N., Doval, D. C., Vaithianathan, H., Banumathy, G., et al. (1997). Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. International Journal of Radiation Oncology Biology Physics, 37(5), 1005-1010.
10. Chi, K. H., Chen, C. H., Chan, W. K., Chow, K. C., Chen, S. Y., Yen, S. H., et al. (1995). Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. Journal of Clinical Oncology, 13(10), 2620-2628.
11. Ryu, J. K., Swann, S., LeVeque, F., Scarantino, C. W., Johnson, D., Chen, A., et al. (2007). The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: A double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. International Journal of Radiation Oncology Biology Physics, 67(3), 643-650.
12. Hassan, S. J., & Weymuller, E. A, Jr. (1993). Assessment of quality of life in head and neck cancer patients. Head and Neck, 15(6), 485-496.
13. Weymuller, E. A, Jr, Alsarraf, R., Yueh, B., Deleyiannis, F. W., & Coltrera, M. D. (2001). Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Archives of Otolaryngology: Head and Neck Surgery, 127(5), 489-493.
14. Sprinzl, G. M., Galvan, O., de Vries, A., Ulmer, H., Gunkel, A. R., Lukas, P., et al. (2001). Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. European Journal of Cancer, 37(16), 2003-2009.
15. Kahn, S. B., Houts, P. S., & Harding, S. P. (1992). Quality of life and patients with cancer: A comparative study of patient versus physician perceptions and its implications for cancer education. Journal of Cancer Education, 7(3), 241-249.
16. Slevin, M. L., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. M. (1988). Who should measure quality of life, the doctor or the patient? British Journal of Cancer, 57(1), 109-112.
17. Movsas, B., Scott, C., Langer, C., Werner-Wasik, M., Nicolaou, N., Komaki, R., et al. (2005). Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation therapy oncology group trial 98-01. Journal of Clinical Oncology, 23(10), 2145-2154.
18. Le, Q. T., Kim, H. E., Schneider, C. J., Murakozy, G., Skladowski, K., Reinisch, S., et al. (2011). Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: A randomized, placebo-controlled study. Journal of Clinical Oncology, 29(20), 2808-2814.
19. Henke, M., Alfonsi, M., Foa, P., Giralt, J., Bardet, E., Cerezo, L., et al. (2011). Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: A randomized, placebo-controlled trial. Journal of Clinical Oncology, 29(20), 2815-2820.
20. Sloan, J. A., Berk, L., Roscoe, J., Fisch, M. J., Shaw, E. G., Wyatt, G., et al. (2007). Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Journal of Clinical Oncology, 25(32), 5070-5077.
21. de Graeff, A., de Leeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. (1999). A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncology, 35(1), 27-32.